        |
    December 13, 2005 : New warnings about Paxil and Paxil CR (paroxetine) The FDA has determined that exposure to Paxil/Paxil CR (paroxetine HCl) in the first trimester of pregnancy may increase the risk for congenital malformations, particularly cardiac malformations. [more...] December 8, 2005 : FamilyCare Selects RxAmerica To Provide PBM Services for Medicare and Medicaid RxAmerica recently announced that it was selected to provide pharmacy benefit management services to FamilyCare Health Plans, Inc.'s Medicare Part D prescription drug programs starting Jan. 1, 2006. [more...] December 2, 2005 : New warnings about NovoSeven (coagulation factor VIIa recombinant) Novo Nordisk and the FDA notified healthcare professionals of revisions to the WARNINGS and ADVERSE REACTIONS sections of the prescribing information for NovoSeven (coagulation factor VIIa recombinant), to provide updated safety information on thrombotic and thromboembolic adverse events, based on clinical studies in non-hemophilia patients and on post-marketing safety surveillance. [more...] December 2, 2005 : New warnings about Aranesp, Epogen and Procrit Amgen, Ortho Biotech and the FDA notified healthcare professionals of revision to the WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION sections of the prescribing information for Aranesp (darbepoetin alfa), Epogen (epoetin alfa), and Procrit (epoetin alfa). [more...] RxAmerica has announced that it was selected to provide pharmacy benefit management services to Unison Health Plan, a government-sponsored managed health care provider currently serving 300,000 members in Ohio, Pennsylvania, South Carolina, and Tennessee. [more...] November 23, 2005 : New warnings about Flomax (tamsulosin) Boehringer Ingelheim and the FDA notified healthcare professionals of revisions to PRECAUTIONS and ADVERSE REACTIONS sections of the prescribing information for Flomax, indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). [more...] November 23, 2005 : Lot Recall GenTeal Gel and Gel Drops Novartis Ophthalmics and the FDA notified healthcare professionals and patients of a voluntary recall due to a lack of sterility assurance of seven lots of two over-the-counter (OTC) products, GenTeal Gel and GenTeal GelDrops, intended for use to relieve dryness of the eye. [more...] November 21, 2005 : New warnings about Advair, Foradil and Serevent Inhalers The FDA has requested that the manufacturers of Advair Diskus, Foradil Aerolizer, and Serevent Diskus update their existing product labels with new warnings and a Medication Guide for patients to alert health care professionals and patients that these medicines may increase the chance of severe asthma episodes, and death when those episodes occur. [more...] FDA notified healthcare professionals and patients of revisions to the label for Ortho Evra, a skin patch approved for birth control, that includes a bolded warning about higher exposure to estrogen for women using the weekly patch compared to taking a daily birth control pill containing 35 micrograms of estrogen. [more...] November 11, 2005 : RxAmerica Serves Medicare Eligible RxAmerica, a leading pharmacy benefit management (PBM) company, announced today that it has contracted with the federal Centers for Medicare & Medicaid Services (CMS) to participate in the Medicare Part D program, as a prescription drug plan sponsor, in 20 regions, covering 35 states and the District of Columbia. [more...] November 10, 2005 : Revised warnings for Avinza Ligand Pharmaceuticals Inc. and FDA notified healthcare professionals of revisions to BOXED WARNING, WARNINGS, PRECAUTIONS, CLINICAL PHARMACOLOGY, and DOSAGE AND ADMINISTRATION sections of the prescribing information to highlight and strengthen the warning that patients should not consume alcohol while taking Avinza. [more...] October 25, 2005 : New warnings about Cylert (Generic Pemoline) The FDA has concluded that the overall risk of liver toxicity from Cylert and generic pemoline products outweighs the benefits of this drug. [more...] October 18, 2005 : New warnings about Cymbalta (Duloxetine) Eli Lilly and FDA notified health care professionals of a revision to the precautions section of the prescribing information for Cymbalta (duloxetine hydrochloride). [more...] The FDA directed Eli Lilly and Company (Lilly), the manufacturer of Strattera (Atomoxetine), to revise the prescribing information to include a boxed warning and additional warning statements that alert healthcare providers of an increased risk of suicidal thinking in children and adolescents during the first few months of being treated with this medication. [more...] September 28, 2005 : New warnings about Paxil and Paxil CR (Paroxetine) GlaxoSmithKline (GSK) and the FDA notified health care professionals of changes to the Pregnancy/Precautions section of the Prescribing Information for Paxil (paroxetine) and Paxil CR controlled-release tablets to describe the results of a GSK retrospective epidemiologic study of major congenital malformations in infants born to women taking antidepressants during the first trimester of pregnancy. [more...] August 2, 2005 : Recall of D-TRON adapters, used with D-TRONplus Insulin Pump Disetronic Medical Systems and FDA notified healthcare professionals and patients about a nationwide recall of D-TRON adapters, used with the D-TRONplus insulin pump, because they can potentially over-deliver a maximum amount of up to 1.8 I.U. (international units) of insulin. [more...] July 15, 2005 : Voluntary suspension of sales and marketing for PalladoneŽ The FDA has issued a public health advisory to notify health care professionals and consumers that the sponsor of PalladoneŽ, Purdue Pharma, has agreed to suspend sales and marketing... [more...] July 8, 2005 : RxAmerica introduces a new logo to reflect company's growth RxAmerica, one of the nation's leading pharmacy benefit management (PBM) companies, recently unveiled a new logo for its company. [more...] June 22, 2005 : RxAmerica launches new Web site designed to be more user-friendly RxAmerica, one of the nation's leading pharmacy benefit management (PBM) companies, is unveiling a new Web site for its company on Wednesday, June 22. [more...] May 25, 2005 : RxAmerica responds to FDA's Indictments against Prescription Drug Distributors On April 28, 2005 the United States Attorney for the District of Utah and the FDA announced a series of indictments against several prescription drug distributors because of their involvement in obtaining and dispensing diverted drugs. [more...] May 9, 2005 : RxAmerica announces agreement with Molina Healthcare RxAmerica has renewed its contract with Molina Healthcare, Inc. to manage the company's prescription benefit services for all new and existing business in California, Michigan, Utah and Washington through June of 2007. [more...]
April 7, 2005 : Pfizer voluntarily withdraws BextraŽ Pfizer announced today, April 7, the voluntary withdrawal of the popular COX-2 BextraŽ (rofecoxib), which is used by millions for treatment of arthritis and acute pain. [more...]
March 14, 2005 : FDA seizes Paxil CR® and Avandamet® On March 9, 2005, the FDA seized Paxil CR® and Avandamet® tablets from several GlaxoSmithKline facilities, due to manufacturing problems. [more...]
February 3, 2005 : RxAmerica recognizes 10 years of success The RxAmerica, recently named one of Utah's "Top Revenue Growth" companies by the Mountain West Venture Group, is celebrating 10 years of success as a manager of prescription benefits. [more...] Archives         |
     |